Predominant role for C5b-9 in renal ischemia/reperfusion injury.
about
Expression of complement components differs between kidney allografts from living and deceased donorsComplement regulation of T-cell alloimmunityTherapeutic regulation of complement in patients with renal disease - where is the promise?The role of complement in the pathogenesis of renal ischemia-reperfusion injury and fibrosisThe Role of Damage-Associated Molecular Patterns in Human Diseases: Part I - Promoting inflammation and immunityEffects of complement activation on allograft injuryEffector mechanisms of rejectionNeutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injuryThe reno-vascular A2B adenosine receptor protects the kidney from ischemiaPericytes and immune cells contribute to complement activation in tubulointerstitial fibrosis.Pathogenesis of acute kidney injury: foundation for clinical practice.Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS.Enterocyte shedding and epithelial lining repair following ischemia of the human small intestine attenuate inflammationComplement component c1q mediates mitochondria-driven oxidative stress in neonatal hypoxic-ischemic brain injury.Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage.Value of plasmatic membrane attack complex as a marker of severity in acute kidney injuryAnaphylatoxin C5a contributes to the pathogenesis of cisplatin-induced nephrotoxicity.Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.Soluble biglycan as a biomarker of inflammatory renal diseases.Identification of a central role for complement in osteoarthritis.The membrane attack complex (C5b-9) in liver cold ischemia and reperfusion injury.Complement factor 3 deficiency attenuates hemorrhagic shock-related hepatic injury and systemic inflammatory response syndrome.Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion.HMGB1 contributes to kidney ischemia reperfusion injury.Defective complement inhibitory function predisposes to renal disease.Elimination of C5aR prevents intestinal mucosal damage and attenuates neutrophil infiltration in local and remote organs.Ischemia/reperfusion Injury and its Consequences on Immunity and Inflammation.Low-density array PCR analysis of reperfusion biopsies: an adjunct to histological analysis.Complement in ischemia reperfusion injury.Pathways to acute humoral rejectionB cell subsets contribute to renal injury and renal protection after ischemia/reperfusion.Binding of factor H to tubular epithelial cells limits interstitial complement activation in ischemic injuryThe complement inhibitors Crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells.CD59a deficiency exacerbates ischemia-reperfusion injury in mice.Update of acute kidney injury: intensive care nephrology.Cellular pathophysiology of ischemic acute kidney injuryPolyglycolic acid-induced inflammation: role of hydrolysis and resulting complement activation.The protective role of CD59 and pathogenic role of complement in hepatic ischemia and reperfusion injuryRole for the alternative complement pathway in ischemia/reperfusion injury
P2860
Q24654702-19A10F7F-4313-45ED-B3EF-AF671DEC0351Q26823956-19B021C1-6349-42D7-88AA-FB4A58809E80Q26851705-B03BF251-4567-499F-871A-9CE98D56E29CQ26853263-4C2ECA82-0AA8-4E08-B141-6F004DFC4D30Q26864215-A40E0CF7-D84F-4D2D-BCBF-7522733F8A83Q26995453-1BD16CB1-7885-41C7-B037-241AFD91FC0BQ27027082-333F3A4D-8160-4063-84D3-3A419BEEED13Q28365738-65E5851D-8CC8-4F6C-964D-04CB268EA2D0Q28473410-C48F5D28-3C68-49E6-B097-3F018CD5CE54Q30275101-E4885622-CDEF-40E6-A22F-120A716107A6Q30425669-CC00C06A-F73A-4FB9-BF1D-1ACC570565F5Q33411421-665C2330-DF63-4799-B1AC-254122702B9EQ33421669-0E0E478D-E363-4C13-9BBA-33F44DFFAEF5Q33503228-AA3ADDA3-8D01-4DE4-8B5D-1E7A6D482B50Q33649734-2E13991B-0D83-4E92-B065-1FC2781877DAQ33745120-05485101-E30E-40C2-9841-35E4E7E37A37Q33747949-0B2AF5DD-75F6-43B8-8AA7-F5F3EF1A5C22Q33792047-CBE59401-5947-4802-8470-3EC4C2EBA63FQ33925353-31E94275-5592-4922-BEFB-9F88DE178038Q34160971-411508D7-6615-46AE-89E8-679045F16B71Q34230334-3D4F5220-699B-4A98-8A7C-3F757F7ABF4BQ34286581-E73C0F40-0DC6-461C-BF88-B90BAFE41B49Q34305737-A964E9E3-DBF6-4EEA-BCB5-DD8137C9C612Q34315819-219CD81D-9262-4D99-8AB5-793DD36DDC8EQ34457038-83C5C913-FB57-4AC8-A24B-BB3B9332707DQ34465747-00506E86-CEE1-4D89-9DD9-19D0CCFAE7F4Q34509114-D2CD0EE7-CB28-4893-ABB3-F41C968318F4Q34532361-FF8C0D38-B14B-494E-BEF4-1388936B6740Q35025490-B63E9632-0FCB-4982-ACB2-D5F30E4D2C7AQ35053536-6631BEAD-210D-455E-B992-28300596BF48Q35096103-831EAE2B-FF94-4D91-BE2E-AA02882D07C8Q35097477-96D9DB03-E72C-44B6-A32F-CA3CAECB8E78Q35097512-A9E33722-F4DE-45AE-A42D-FC7D0CAA4E01Q35097528-4F854A8A-16DD-44D3-8897-7EBF98F7B31FQ35103059-69D7CCBF-F05B-4213-A0E7-9045099A4CF3Q35115570-E9D82D78-3C59-4970-B0AA-8B619916E2DFQ35484725-2CF7C3A1-7E0A-4902-BB16-F221223A83B5Q35585813-B28DEBB2-D0F6-4A0C-BB03-7BB447D72526Q35679518-FDD53E84-9C71-471D-808C-9E61A8B2317DQ35748956-9E54E610-3403-491F-8489-FABFD1109FCA
P2860
Predominant role for C5b-9 in renal ischemia/reperfusion injury.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Predominant role for C5b-9 in renal ischemia/reperfusion injury.
@en
type
label
Predominant role for C5b-9 in renal ischemia/reperfusion injury.
@en
prefLabel
Predominant role for C5b-9 in renal ischemia/reperfusion injury.
@en
P2093
P2860
P356
P1476
Predominant role for C5b-9 in renal ischemia/reperfusion injury
@en
P2093
C A Farrar
P2860
P304
P356
10.1172/JCI8621
P407
P577
2000-05-01T00:00:00Z